Dr. Nakhate is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2020 - 2023
- Harvard Medical SchoolClass of 2019
Certifications & Licensure
- MA State Medical License 2019 - 2025
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes.Tyler A Lanman, Gilbert Youssef, Raymond Huang, Rifaquat Rahman, Matthew DeSalvo
Neuro-Oncology Advances. 2024-12-19 - Altered Mental Status in Cancer.John Y Rhee, Vihang Nakhate, Christy Soares, Zachary Tentor, Jorg Dietrich
Seminars in Neurology. 2024-12-01 - 3 citationsThe Role of Mutant IDH Inhibitors in the Treatment of Glioma.Vihang Nakhate, Aleksandra B Lasica, Patrick Y Wen
Current Neurology and Neuroscience Reports. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: